Form 4: SOPHiA GENETICS CFO Sells Shares for Tax Obligations

SOPHiA GENETICS Chief Financial Officer George Cardoza sold 774 ordinary shares to cover tax liabilities from restricted stock unit vesting.

Summary

• George Cardoza, Chief Financial Officer of SOPHiA GENETICS SA, reported a sale of 774 ordinary shares.
• The transaction occurred on March 19, 2026, at a weighted average price of $4.7862 per share.
• The sale was executed to satisfy tax withholding obligations arising from the vesting of restricted stock units on March 18, 2026.
• This sale was conducted pursuant to a pre-established Rule 10b5-1 trading plan, indicating it was not a discretionary trade.
• Following the transaction, Mr. Cardoza beneficially owns 184,858 ordinary shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine, non-discretionary sale of shares by the CFO to cover tax obligations from RSU vesting, executed under a pre-established Rule 10b5-1 plan.

Positives

• The sale was conducted under a pre-established Rule 10b5-1 trading plan, which demonstrates transparency and reduces concerns about opportunistic insider trading.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to tax obligations from RSU vesting and executed under Rule 10b5-1 plans, are common occurrences across all industries for publicly traded companies. They typically do not reflect a change in management's outlook on the company's prospects but rather a routine financial event.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, non-discretionary transaction by a corporate officer to cover tax liabilities, not indicative of a change in company fundamentals or management's confidence.

Key Dates

Keywords

SOPHiA GENETICS, SOPH, Form 4, Insider Transaction, Stock Sale, CFO, Rule 10b5-1, Tax Withholding, Restricted Stock Units